{"disease":{"id":"colorectal-cancer-microsatellite-stable-mss","name":"colorectal cancer microsatellite stable mss"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03549000","title":"A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":127,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07446465","title":"FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Ye Xu","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}